Psst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveCLEATUS Webinar: AI for Government Contracting — Free Webinar — Wednesday, August 5 at 2:00 PM EDT

Register Free →

Get CLEATUSFree Trial

Get CLEATUSFree Trial

Search

Top

Back to Contracts

Pharmaceutical Product Supply – Electrolyte Injection

Active

Federal

Response Deadline08/04/2026, 05:00:00 PM UTC

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

AI Contract Overview

Show more

The contract pertains to the supply of FDA-regulated Multiple Electrolytes Injection, Type 1, USP, packaged in 1000 mL latex-free plastic bags, adhering to current good manufacturing practices and United States Pharmacopeia standards, including all applicable shelf-life and quality requirements. The product must meet stringent regulatory and safety benchmarks to ensure suitability for clinical use within military and federal healthcare systems. The solicitation, issued under the Medical Supply Chain Pharm FSA, part of the Department of Defense, is categorized as a subcontract with a NAICS code of 325412, indicating pharmaceutical preparation manufacturing. It was posted on July 29, 2026, with a response deadline of August 4, 2026, and requires performance at Fort Bragg, North Carolina, with a zip code of 28310. Bidders must demonstrate full compliance with cGMP, USP specifications, and packaging integrity standards to qualify for award.

General Info

Supply of FDA-compliant electrolyte injection in 1000 mL bags for military use, meeting cGMP and USP standards at Fort Bragg.

Agency

Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSAView Agency

NAICS

325412 - Pharmaceutical Preparation ManufacturingView NAICS

Place of Performance

FORT BRAGG, NC, 28310, US

Set-Aside

NONE

Documents

(0)

No documents available

AI Contract Breakdown

Uniform Contract Format

No contract breakdown available.

Cannot generate Contract Breakdown because no documents were found from this contract's source.

Timeline

PostedJul 29

subcontract

Response DeadlineAug 4

Submission deadline

Response Deadline

08/04/2026, 05:00:00 PM UTCin 4 days

Ready to pursue this opportunity?

Start your free trial to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more

AgencyDepartment Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA

ContactsNo contacts available

OfficeN/A

Organization / Agency

Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA

View Agency Profile

Office AddressN/A

ContactsNo contact information available

Full Description

Show more

Supply of FDA-regulated Multiple Electrolytes Injection, Type 1, USP in 1000 mL latex-free plastic bags, compliant with cGMP, USP standards, and shelf-life requirements.

Similar Contracts

Same NAICS industry code

Azithromycin Tablets Solicitation

Solicitation # SPE2D2-26-R-0008

The solicitation SPE2D2-26-R-0008 for Azithromycin Tablets is a Lowest Price Technically Acceptable (LPTA) acquisition issued by the Defense Logistics Agency under the Department of Defense, targeting pharmaceutical suppliers to provide specified tablet formulations in unit-of-use packaging meeting stringent regulatory and technical standards. The contract encompasses five clinical line items for 250mg, 500mg, and 600mg azithromycin tablets in 6-count, 3-count, and 30-count bottles, with base quantities for each and four one-year option periods allowing for a potential five-year contract duration. Technical acceptability is strictly gated by compliance with current Good Manufacturing Practices, FDA licensing through an approved NDA, ANDA, or BLA, therapeutic equivalence “A” ratings, adherence to the Drug Supply Chain Security Act, and full disclosure of manufacturing facility locations and foreign ownership status. The packaging must be child-proof, cylindrical with minimum dimensional specifications, free of glass, and compatible with automated dispensing systems like Baxter ATC and OptiFill, while requiring GS1-128 or HIBCC barcode labeling at the unit level with NDC, lot number, and expiration date encoded to ANSI/ISO/IEC quality grade C or higher, avoiding barcode placement across perforations or in proximate pairs. Offerors must submit electronic proposals via the DIBBS portal in two volumes—one technical compliance package and one price proposal—with no page limits, but failure to address mandatory representations under FAR 52.204-19, DFARS 252.204-7018, and other referenced clauses results in disqualification. Past performance and technical compliance are evaluated as pass/fail gates before price is considered as the sole award criterion. Delivery is FOB destination to DLA and VA Prime Vendor distribution centers, with performance commencing 45 days after award and pricing effective 15 days after that. Contract payments are routed through Prime Vendor contractors, not directly by the government, and rights to payment cannot be assigned. The closing date has been amended to August 12, 2026, at 3:00 PM EDT, with proposals requiring valid UEI and CAGE codes and certification of small business or other socioeconomic status if applicable. The procurement excludes covered telecommunications equipment and requires full disclosure of country of origin for both active pharmaceutical ingredients and final products, with no tolerance for uncorrected FDA violations

Defense Logistics Agency

POSTED

about 19 hours ago

DEADLINE

6505--Ticagrelor Tablets

Solicitation # 36E79726R0028

The Department of Veterans Affairs through its National Acquisition Center is preparing to issue an unrestricted solicitation for Ticagrelor Tablets under solicitation number 36E79726R0028, targeting supply to VA facilities including Consolidated Mail Order Pharmacies and State Veterans Homes, as well as the Department of Defense, Bureau of Prisons, Indian Health Service, and Federal Health Care Centers. The procurement is divided into two mutually exclusive groups: Group I includes both 60-count bottles and bulk packaging options of 500 or 1,000 tablets per bottle for both 60mg and 90mg strengths, while Group II includes only 60-count bottles for the same strengths. Offerors must submit complete proposals for one group only, and award will go to the lowest-priced technically acceptable bid based on total evaluated price. The contract has a base term of one year with four optional one-year extensions, and product distribution will be managed through the VA and DoD Pharmaceutical Prime Vendor Programs. All offered products must bear the offeror’s unique NDC number and be labeled exclusively with that label, with no over-labelling permitted. VA labels must be capable of adhering securely on top of the contractor’s label. Packaging requirements are strict: unit-of-use bottles must have safety caps with deshellable or convertible features, meet minimum size specifications including 120cc capacity and 5.75-inch circumference, fit a label measuring 5.25 x 2 inches with an additional 0.5 inch for barcodes and expiration details, and feature a cylindrical body. Total annual estimated demand is approximately 21,137 bottles of 60mg 60-count, 141,992 bottles of 90mg 60-count for Group I combined with either 500 or 1,000 tablet bulk options, and for Group II, approximately 52,237 and 205,992 bottles of 60mg and 90mg 60-count respectively. The solicitation will be released electronically on or about August 18, 2026, with a proposed closing date of September 1, 2026, under NAICS code 325412. All information is accessible only through SAM.gov, and inquiries must be directed via email to Kenneth Lay. No paper copies will be provided.

Nac Pharmaceuticals (36E797)

POSTED

about 19 hours ago

DEADLINE

ACAN tecovirimat

Solicitation # WS5801165980

The Government of Canada, through the Department of Public Works and Government Services, has issued a solicitation for the procurement of tecovirimat under reference number WS5801165980, posted on July 30, 2026, with responses due by August 18, 2026. This federal opportunity is open to qualified suppliers and is intended for delivery within Canada, with no specific set aside or NAICS code identified. The contract is managed by the Contracting Authority, Anja Ramenason of SPAC/PSPC, who can be contacted via email at anja.ramenason@tpsgc-pwgsc.gc.ca for inquiries or additional information regarding the procurement process. The solicitation seeks to secure tecovirimat, an antiviral drug likely intended for national preparedness or public health use, under a federal acquisition framework. All responses must adhere to the specified timeline, and potential offerors are encouraged to review the full tender details via the official Canada Buys portal link provided. Performance of the contract is expected to occur across Canada without a designated local address, reflecting a nationwide scope of delivery and distribution. No physical office address is listed for the contracting office, indicating a centralized federal procurement structure.

Department of Public Works and Government Services

POSTED

DEADLINE

Pharmaceutical Tablet Supply – Sumatriptan Succinate 25mgThe contract entails the manufacture and supply of 54,000 units of Sumatriptan Succinate 25mg film-coated tablets intended for the acute treatment of migraines, with strict adherence to current Good Manufacturing Practices (cGMP) requirements to ensure product quality, safety, and consistency. The manufacturing process and final product must comply with controlled storage conditions to maintain stability and efficacy throughout the supply chain, reflecting the sensitive nature of pharmaceutical therapeutics. The procurement is structured as a subcontract under the NAICS code 325412, which designates pharmaceutical preparation manufacturing, and is managed by the Department of Defense through its Medical Supply Chain Pharm FSA agency, with performance required at Fort Bliss, Texas, 79918-2527. The solicitation was posted on July 29, 2026, with a response deadline of August 4, 2026, indicating a tight turn-around for qualified suppliers to submit proposals. The contract is not subject to any set-aside provisions and is publicly accessible via the DIBBS platform, suggesting a competitive bidding process open to eligible contractors capable of meeting federal pharmaceutical standards. Compliance with all regulatory, packaging, labeling, and documentation requirements for defense-related medical supplies will be mandatory, and delivery timelines will likely be tied to operational readiness needs of the military healthcare system.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Supply of Benzoic Tincture, Compound, USP (NSN: 6505016549628)The contract entails the procurement and delivery of Benzoic Tincture, Compound, USP in bulk containers under the National Stock Number 6505016549628, with a response deadline of August 4, 2026. This is a subcontract issued by the Department of Defense through the Medical Supply Chain Pharm FSA, and the material must be delivered to a military address identified as APO with zip code 09094-3219. All supplies must strictly adhere to federal, military, and transportation regulations governing the packaging, labeling, and shipment of medical substances to ensure safety and compliance during transit. The work falls under the NAICS code 325412, indicating pharmaceutical manufacturing, and requires the vendor to meet all applicable standards for handling and transporting controlled medical products to government-operated facilities.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Pharmaceutical Manufacturing and Packaging of Morphine Sulfate InjectionThe contract requires the manufacture, labeling, and packaging of Morphine Sulfate Injection at a concentration of 10mg/mL in 1x10 NEXJECT units, classified as a DEA Schedule II controlled substance, ensuring strict compliance with all applicable federal regulations including those set by the FDA, OSHA, and DLA. The product must adhere to precise quality, safety, and documentation standards appropriate for a high-risk controlled pharmaceutical, with packaging and labeling meeting all regulatory requirements for traceability, security, and handling. The work is to be performed at the designated place of performance in APO with ZIP code 09094-3219, under the oversight of the Department of Defense through the Medical Supply Chain Pharm FSA, and the solicitation is issued as a subcontract with a NAICS code of 325412 for pharmaceutical preparation manufacturing. Responses to this solicitation are due by August 4, 2026, with the opportunity published on July 29, 2026, indicating a limited bid window of one week. All proposals must demonstrate proven capability in handling DEA Schedule II substances, robust quality control systems, validated packaging processes, and full compliance with federal controlled substance handling protocols. The nature of the product and the federal context necessitate secure, auditable manufacturing practices with no tolerance for deviation from regulatory standards, and successful contractors must be equipped to meet the stringent demands of military medical supply chains while maintaining uninterrupted availability of this critical pain management medication.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Pharmaceutical Manufacturing and Supply – Benzonatate CapsulesThe contract solicits the manufacture and supply of Benzonatate Capsules, USP, 100 mg, in bottles containing 100 units each, adhering strictly to FDA regulations, current Good Manufacturing Practices, and Department of Defense Defense Logistics Agency technical specifications. All packaging, labeling, and product documentation must comply with required NDC standards and DLA packaging guidelines to ensure full regulatory and logistical compatibility. The product must be produced in a facility certified for pharmaceutical manufacturing and capable of consistent quality control throughout the production lifecycle. This subcontract is issued under the NAICS code 325412 by the Department of Defense through the Medical Supply Chain Pharm FSA, with performance required at Fort Bragg, North Carolina, 28310. The solicitation was posted on July 29, 2026, and responses are due by August 4, 2026, with no set-aside provisions indicated. Interested parties must meet all technical and compliance requirements to be considered, with the expectation that the delivered product will be integrated into federal medical supply systems for distribution to military and defense healthcare facilities.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Supply of Pharmaceutical-Grade Activated Charcoal (NSN 6505-01-282-8880)The contract is for the supply of four bulk tons of pharmaceutical-grade activated charcoal compliant with USP and military pharmaceutical standards, identified by NSN 6505-01-282-8880, to be delivered to DLA Troop Support under a subcontract arrangement. The product must meet rigorous quality specifications set for use in defense and medical applications, ensuring consistency and safety for critical purposes. The North American Industry Classification System code 325412 indicates the manufacturing category for pharmaceutical preparations, underscoring the technical precision required in production and packaging. Though the solicitation number is not provided, the contract reference is tied to the award number SPE2DX25D9900 and delivery order SPE2DP26F3783, indicating it is part of an established procurement workflow managed by the Defense Logistics Agency under the Department of Defense. The contract was posted on July 29, 2026, and while specific delivery locations and point of contact details are not listed, the performance location and recipient are clearly aligned with DLA’s logistics network. The requirement is non-competitive and not subject to a set-aside, meaning any qualified subcontractor meeting the specifications may be eligible to fulfill the order.

Defense Logistics Agency

POSTED

DEADLINE

Typhoid Vaccine Supply and PackagingThe contract involves the supply of 10 mL vials containing a modified, acellular Typhoid Vi Polysaccharide Vaccine, requiring full compliance with labeling, packaging, and hazardous materials documentation standards. The product must meet strict regulatory and safety specifications to ensure safe handling, transport, and administration, with all materials and processes aligned to industry and governmental requirements. The vaccine is intended for use within the Department of Defense’s medical supply chain, and the contractor is expected to deliver fully qualified and documented shipments to the designated performance location. The solicitation, issued under the NAICS code 325412 for pharmaceutical preparation manufacturing, is structured as a subcontract with a response deadline of August 4, 2026, and a posted date of July 29, 2026. Deliveries must be directed to FPO with ZIP code 96691-3300, reflecting its military logistics context. The contracting entity is the Medical Supply Chain Pharm FSA under the Department of Defense, indicating the vaccine will support military health operations. All aspects of the order, from manufacturing to documentation, must adhere to federal defense standards without reliance on set-aside provisions, and the contract is accessible via the DIBBS platform for official reference.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Supply of Silver Nitrate Applicators for Military Medical UseThe contract entails the manufacture and supply of sterile, individually packaged silver nitrate applicators compliant with stringent military medical standards, intended for use by U.S. Department of Defense medical personnel. These applicators must meet precise quality and safety requirements to ensure reliable performance in field and clinical settings, with delivery directed to DLA Troop Support facilities at Joint Base Pearl Harbor-Hickam, identified by zip code 96853-5256. The solicitation, categorized as a subcontract under NAICS code 325412, is issued by the Medical Supply Chain Pharm FSA under the Department of Defense and requires responses by August 3, 2026. All products must be packaged individually and meet the regulatory, sterilization, and labeling specifications dictated by military medical procurement guidelines to guarantee compatibility and safety in operational environments.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Small Business Set-Aside Participation OpportunityThe contract offers subcontracting opportunities specifically reserved for small or disadvantaged businesses, including those owned by women, to participate in manufacturing, packaging, or logistics activities under a prime contract led by a WOSB or EDWOSB entity. These roles are part of a broader procurement initiative managed by the Defense Logistics Agency under the Department of Defense, with the North American Industry Classification System code 325412 identifying the focus on pharmaceutical and medicine manufacturing support functions. While no solicitation number or specific point of contact is provided, the opportunity is publicly accessible through the DIBBS portal and emphasizes inclusion of eligible small and disadvantaged firms to fulfill critical supply chain functions in support of federal defense logistics needs. The posting date indicates the opportunity was made available in 2026, aligning with upcoming contract performance timelines.

Defense Logistics Agency

POSTED

DEADLINE

Supply of Activated Charcoal (Pharmaceutical Grade)The contract entails the procurement and delivery of pharmaceutical-grade activated charcoal designated by NSN 6505-01-282-8880, supplied as a commercial item fully compliant with federal and Department of Defense specifications. This subcontract, under the NAICS code 325412, is managed by the Defense Logistics Agency within the Department of Defense and aims to fulfill operational medical requirements through the reliable supply of a critical pharmaceutical agent. The item must meet stringent quality and purity standards inherent to pharmaceutical-grade materials, ensuring suitability for use in military medical settings. Delivery is governed by the contract awarded under SPE2DX25D9900 with a associated delivery order SPE2DP26F3890, and performance is expected to support the logistical needs of the DoD without specifying a geographical place of performance. The solicitation was posted on July 29, 2026, indicating the timeline for fulfillment and adherence to contractual obligations. The procurement process follows established commercial item acquisition protocols, emphasizing efficiency, compliance, and readiness to meet mission-critical health and safety standards across defense operations.

Defense Logistics Agency

POSTED

DEADLINE

More opportunities from Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA

Same awarding agency

Small Business Subcontracting & Compliance SupportThe contract seeks a vendor to assist the prime contractor in achieving small business subcontracting objectives by identifying, coordinating with, and ensuring compliance for Women-Owned Small Businesses, Service-Disabled Veteran-Owned Small Businesses, and HUBZone certified firms. The support includes proactive outreach to eligible vendors, managing subcontractor relationships, and providing accurate and timely compliance reporting to meet federal small business participation targets. This effort is tied to a Department of Defense initiative under the Medical Supply Chain Pharm FSA, with performance centered at Fort Bliss, Texas, 79918-2527, and aligns with NAICS code 541611 for management consulting services. The opportunity is open for responses until August 4, 2026, with the solicitation posted on July 29, 2026. While no specific set-aside designation is indicated, the work is explicitly structured to enable prime contractors to fulfill their small business subcontracting obligations, particularly through engagement with certified disadvantaged and underrepresented business entities. The contracting vehicle falls under the subcontract category, and all activities must adhere to federal small business programs and reporting requirements applicable to Department of Defense contracts. Interested parties can access further details through the provided DIBBS portal link.

Administrative Management and General Management Consulting Services

POSTED

DEADLINE

Domestic and International Pharmaceutical Shipping & Freight LogisticsThe contract requires the transport of temperature-sensitive pharmaceuticals under strict compliance with MIL-STD-247-7023 standards to ensure product integrity throughout the supply chain. All shipments must facilitate continuous chain-of-custody tracking, specifically for military delivery destinations, with Fort Bliss, Texas serving as the primary place of performance. The logistics provider must maintain rigorous documentation and real-time monitoring for both domestic and international movements, ensuring adherence to military-grade handling protocols for sensitive medical cargo. This is a subcontract opportunity under NAICS code 488510, managed by the Department of Defense through the Medical Supply Chain Pharm FSA, with proposals due by August 4, 2026.

Freight Transportation Arrangement

POSTED

DEADLINE

Pharmaceutical Packaging, Labeling, and PalletizationThe contract requires the packaging, labeling, and palletization of Sumatriptan tablets in full compliance with DLA standards, emphasizing light protection to preserve pharmaceutical integrity, MIL-STD-129 marking for uniform military identification, and adherence to RP001 and MIL-STD-2073-1E for secure and standardized palletization. All work must be performed to ensure logistical readiness and traceability within the Department of Defense supply chain. The project is classified as a subcontract under NAICS code 323111, with a response deadline of August 4, 2026, and the place of performance is designated as Fort Bliss, Texas, 79918-2527. The contracting activity falls under the Medical Supply Chain Pharm FSA within the Department of Defense, indicating its critical role in supporting military medical operations through reliable pharmaceutical logistics.

Commercial Printing (except Screen and Books)

POSTED

DEADLINE

Hazardous Materials Compliance & Safety Data Sheet (SDS) ManagementThe contract requires identification of hazardous components within pharmaceutical products and the preparation of Safety Data Sheets (SDS) that comply with OSHA’s Hazard Communication Standard and Federal Standard No. 313 to ensure regulatory alignment. All SDS documentation must meet precise technical and formatting requirements to support safe handling, storage, and disposal of hazardous pharmaceutical materials used within the Department of Defense supply chain. The work is scoped under subcontract and centered on ensuring compliance with federal safety regulations for materials processed or distributed through the Medical Supply Chain Pharm FSA. Performance is required at Fort Bliss, Texas, with a response deadline of August 4, 2026, and the contract falls under NAICS code 541690 for other scientific and technical consulting services. This effort supports the Department of Defense’s obligation to maintain safety and regulatory integrity across its pharmaceutical supply chain, emphasizing precision in hazard identification and standardized reporting. All deliverables must be accurate, timely, and fully aligned with current federal guidelines to facilitate seamless operations and regulatory audits.

Other Scientific and Technical Consulting Services

POSTED

DEADLINE

Supplier of Ready-Made Pharmaceutical Packaging Compliant with DLA StandardsThe contract seeks a supplier to provide pre-approved, sealed pharmaceutical packaging that meets stringent military standards for medical-grade protection and durability, specifically complying with MIL-STD-2073-1E and DLA RP001. These requirements ensure the packaging maintains integrity under harsh environmental conditions, supports long-term storage, and safeguards pharmaceutical integrity during transport and deployment, particularly for use by U.S. military medical personnel. The packaging must be ready-made and fully compliant without requiring additional modification upon receipt. The opportunity is structured as a subcontract under the NAICS code 326199, with performance designated to occur at APO 09094-3219, indicating delivery to a U.S. military diplomatic or overseas location. The solicitation was posted on July 29, 2026, with a response deadline of August 4, 2026, providing a narrow seven-day window for submissions. The procuring entity is the Medical Supply Chain Pharm FSA under the Department of Defense, underscoring the critical nature of this supply for military health readiness. All proposals must align precisely with DLA specifications to ensure seamless integration into federal medical logistics systems.

All Other Plastics Product Manufacturing

POSTED

DEADLINE

Government Marking Removal for Non-Accepted SuppliesThe contract requires the removal of government markings from pharmaceutical supplies that have been rejected or not accepted, in accordance with DLA Clause RQ011, to ensure proper disposal or return procedures are followed. This task is critical to maintain compliance with federal regulations and protect sensitive information associated with government-issued materials. The work must be performed by a subcontractor under the authority of the Department of Defense's Medical Supply Chain Pharm FSA, with all activities centered at the designated place of performance in APO, ZIP 09094-3219. The solicitation is classified under NAICS code 562990 for other remediation services and is open for response until August 4, 2026, with the posting date listed as July 29, 2026. The subcontract nature of the agreement suggests the primary contractor will delegate the marking removal process, requiring precise adherence to handling protocols to avoid regulatory noncompliance or security breaches.

POSTED

DEADLINE

Cybersecurity and Covered Defense Information (CDI) SafeguardingThe contract requires the implementation and maintenance of cybersecurity controls to safeguard Covered Defense Information in accordance with NIST SP 800-171 and DFARS 252.204-7012, ensuring that all systems handling sensitive defense data meet federal standards for protection. This subcontract is aimed at securing information systems against unauthorized access, disclosure, or compromise, with specific focus on technical, administrative, and physical safeguards defined by the referenced frameworks. Compliance is mandatory and must be demonstrated throughout the performance period, with continuous monitoring and documentation of control effectiveness as a core expectation. The work is to be performed at the APO location with zip code 09094-3219, under the oversight of the Department of Defense through the Medical Supply Chain Pharm FSA. The solicitation was posted on July 29, 2026, with responses due by August 4, 2026, indicating a tight turnaround for proposers to demonstrate capability and readiness. The NAICS code 541512 identifies the work as related to computer systems design services, suggesting the need for specialized technical expertise in cybersecurity architecture and integration. All parties must be prepared to meet rigorous compliance standards, maintain audit-ready records, and ensure ongoing adherence to federal cybersecurity requirements without exception.

Computer Systems Design Services

POSTED

DEADLINE

Shelf-Life Monitoring and Inventory Management for Type I, Code K ItemsThe contract requires comprehensive management of shelf-life tracking and inventory rotation for Morphine Sulfate, a controlled Type I, Code K pharmaceutical item with a strict 18-month non-extendable shelf life, in full compliance with Defense Logistics Agency standards. All activities must ensure timely identification, labeling, and prioritized distribution of stock to prevent expiration and maintain regulatory compliance, with no tolerance for shelf-life extension or deviation from the established timeline. Performance is centered at APO, ZIP 09094-3219, under a subcontract structure governed by NAICS code 493110, with responses due by August 4, 2026. The contracting entity is the Department of Defense through the Medical Supply Chain Pharm FSA, and all operations must align with federal pharmaceutical logistics protocols to safeguard the integrity, security, and availability of this critical controlled substance within the military supply chain.

General Warehousing and Storage

POSTED

DEADLINE

Hazardous Materials Compliance and Safety Data Sheet (SDS) ManagementThe contract requires the preparation, maintenance, and timely submission of Safety Data Sheets for pharmaceutical components, ensuring full compliance with OSHA’s Hazard Communication Standard under 29 CFR 1910.1200. This includes accurate labeling of all hazardous materials to meet federal regulatory requirements, with a focus on consistency, clarity, and regulatory alignment throughout the supply chain. The work must be performed to support the Department of Defense’s Medical Supply Chain Pharmaceutical FSA, with performance centered at the APO zip code 09094-3219. This is a subcontract governed under NAICS code 541620, which corresponds to scientific and technical consulting services, indicating the need for specialized expertise in chemical safety and regulatory documentation. Responses are due by August 4, 2026, and the solicitation was posted on July 29, 2026. The contract does not specify a set-aside type or point of contact, and all work must be executed through the DIBBS platform using the provided solicitation number SPE2DP26T4360. Compliance with OSHA standards is non-negotiable, and any failure in SDS accuracy or labeling could result in regulatory violations and supply chain disruption.

Environmental Consulting Services

POSTED

DEADLINE